Resmed Inc. buy Needham & Company LLC
Start price
25.01.24
/
50%
€173.80
Target price
25.01.25
€197.59
Performance (%)
36.54%
End price
26.01.25
€237.30
Summary
This prediction ended on 26.01.25 with a price of €237.30. The BUY prediction by Needham___Company_LL for Resmed Inc. saw massive gains of 36.54%. A total of €1.87 was paid as dividends for this prediction. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -2.046% | -2.046% | -3.443% |
| iShares Core DAX® | -3,51 % | -8,75 % | -1,00 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % | 14,22 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % | 24,87 % |
| iShares S&P 500 | -2,60 % | -2,23 % | 9,20 % |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $180.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten